Abstract
In This Issue...
In vitro diagnostics (IVD) and molecular diagnostics are multibillion-dollar
industries. Together, they play critical roles in the trend toward
personalized medicine. Pharmaceutical and biotechnology companies are turning
to personalized medicine to help improve the drug development process and
speed the approval of new drugs. In this report, we discuss the role of IVD
and molecular diagnostics in personalized medicine, profile companies in the
field, discuss key trends and issues, and ponder the future of personalized
medicine.
View Cart
